Indoco Remedies peers

Companies like Indoco Remedieslatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

INDOCO₹213.75

Indoco Remedies Limited

· Pharma & Health
₹ CrorePeersSAIPARENTPANACEABIOHIKALWINDLASHESTERBIODCALSYNCOMFSOLARAMcap ₹1,973 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
INDOCO
FY26
SAIPARENT
FY26
PANACEABIO
FY26
HIKAL
FY26
Peer
Average
Valuation — at last close
P/E—111.02×——111.02×
P/B2.10×4.36×2.42×◆ 2.08×2.95× -29%
EV/EBITDA20.94×52.86×◆ -420.68×14.35×-117.82× +118%
Market Cap₹1,973 Cr₹2,139 Cr₹2,017 Cr₹2,496 Cr₹2,217 Cr -11%
Growth
Revenue CAGR 3Y3.41%—◆ 11.63%-5.40%3.12% +9%
Revenue CAGR 5Y◆ 8.25%—0.47%-0.09%0.19% +4242%
Revenue YoY (latest Q)7.32%—◆ 19.72%5.89%12.80% -43%
Net Income YoY (latest Q)◆ 311.40%—-44.44%66.96%11.26% +2666%
Profitability
EBITDA Margin7.68%10.16%-0.73%◆ 12.87%7.43% +3%
Net Income Margin-5.35%◆ 3.74%-1.12%-2.85%-0.08% -6878%
Return on Common Equity-9.70%◆ 2.91%-0.64%-3.97%-0.57% -1612%
Return on Capital Employed0.97%2.57%-4.11%◆ 3.30%0.59% +65%
Return on Assets-3.93%◆ 1.00%-0.56%-1.99%-0.52% -661%
Credit & Quality
Total Debt/Equity1.11×0.65×◆ 0.03×0.57×0.42× +166%
Interest Coverage0.13×◆ 1.18×-6.23×0.91×-1.38× +109%
Scale — latest FY
Revenue / Total Income₹1,845 Cr₹381 Cr₹640 Cr₹1,713 Cr₹911 Cr +103%
Net Income−₹98.7 Cr₹14.3 Cr−₹7.2 Cr−₹48.8 Cr−₹13.9 Cr -610%
Total Assets₹2,593 Cr₹1,424 Cr₹1,262 Cr₹2,365 Cr₹1,684 Cr +54%
EPS₹-10.7₹4.36₹-0.88₹-3.96₹-0.16 -6588%
Book Value per Share₹101.76₹111.08₹136.19₹97.07₹114.78 -11%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.